New drug BL-B01D1 enters human trials for Hard-to-Treat cancers

NCT ID NCT05194982

Recruiting now Disease control Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new drug called BL-B01D1 in people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find a safe dose, and second, to check how well that dose works and how the body handles it. About 570 participants will take part to help determine if this drug is worth studying further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: BL-B01D1 (a drug given by IV infusion)
What this could lead to: If it works, this could point toward a new treatment option for people with advanced solid tumors that have not responded to standard therapies.
What could go wrong: This is an early Phase 1 trial focused on safety and dosing, so it is too soon to know if the drug will be effective. Side effects are possible and will be closely monitored.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms Neoplasm Metastasis non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED OR METASTATIC SOLID TUMOR

Contacts and locations

Locations

Chongqing University Cancer Hospital
RECRUITING

Chongqing, Chongqing Municipality, China
Hunan Cancer Hospital
RECRUITING

Changsha, Hunan, China
Renmin Hospital of Wuhan University
RECRUITING

Wuhan, Hubei, China
Shanghai Oriental Hospital
RECRUITING

Shanghai, Shanghai Municipality, China
Shanxi Cancer Hospital
RECRUITING

Taiyuan, Shanxi, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510060, China
The Second Affiliated Hospital of Guangzhou Medical University
RECRUITING

Guangzhou, Guangdong, China
Union Hospital Tongji Medical College, Huazhong University of Science and Technology
RECRUITING

Wuhan, Hubei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.